These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16480587)

  • 1. [Clinical analysis of 1,142 hospitalized cantonese patients with nasopharyngeal carcinoma].
    Cao SM; Guo X; Li NW; Xiang YQ; Hong MH; Min HQ
    Ai Zheng; 2006 Feb; 25(2):204-8. PubMed ID: 16480587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
    Ling W; Cao SM; Huang QH; Li YH; Deng MQ
    Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China.
    Jia WH; Feng BJ; Xu ZL; Zhang XS; Huang P; Huang LX; Yu XJ; Feng QS; Yao MH; Shugart YY; Zeng YX
    Cancer; 2004 Jul; 101(2):363-9. PubMed ID: 15241835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A dynamic study on titer of EB virus VCA/IgA and EA/IgA in nasopharygeal carcinoma patients].
    Ji MF; Guo YQ; Liang JS; Zheng SA; Cheng WM; Yu BH; Ou XT; Wang DK
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):243-5. PubMed ID: 12839685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological survey of nasopharyngeal carcinoma in 21 cities of south China.
    Deng H; Zeng Y; Lei Y; Zhao Z; Wang P; Li B; Pi Z; Tan B; Zheng Y; Pan W
    Chin Med J (Engl); 1995 Apr; 108(4):300-3. PubMed ID: 7789220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
    Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
    Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological study of nasopharyngeal carcinoma risk in relatives of high-risk families in Guangdong].
    Jia WH; Xu ZL; Feng BJ; Huang LX; Yu XJ; Feng QS; Zhang F; Zeng YX
    Ai Zheng; 2004 Jul; 23(7):767-70. PubMed ID: 15248909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nasopharyngeal carcinoma (NPC) mortality rate in two districts of Guangdong Province and their relation to IgA antibody level against EB virus capsid antigen].
    Zong YS
    Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):103-5. PubMed ID: 1319889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
    Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study on risk factors and family history of familial and sporadic nasopharyngeal carcinoma patients].
    Luo XY; Liu WS; Chen LZ; Feng QS; Zeng YX; Jia WH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):293-8. PubMed ID: 19534949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
    J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex segregation analysis of nasopharyngeal carcinoma in Guangdong, China: evidence for a multifactorial mode of inheritance (complex segregation analysis of NPC in China).
    Jia WH; Collins A; Zeng YX; Feng BJ; Yu XJ; Huang LX; Feng QS; Huang P; Yao MH; Shugart YY
    Eur J Hum Genet; 2005 Feb; 13(2):248-52. PubMed ID: 15483644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus seroepidemiology in China.
    Zeng Y; Pi GH; Deng H; Zhang JM; Wang PC; Wolf H; De Thé G
    AIDS Res; 1986 Dec; 2 Suppl 1():S7-15. PubMed ID: 3030349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma.
    Zhang C; Zong Y; Huang B; Sun Y; Ye Y; Feng K; Li J; Zhang F
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):356-9. PubMed ID: 12408763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.